Biodexa Pharmaceuticals (BDRX) Interest Coverage Ratio (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) posted Interest Coverage Ratio of 29.75 for Q2 2025, down 65.48% sequentially from 86.18 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Interest Coverage Ratio (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has reported Interest Coverage Ratio for 12 years, with the latest figure at 29.75 in Q2 2025.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 29.75 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 104.44 (changed N/A YoY) and the FY2025 annual result came in at 37.75, up 167.71% from the prior year.
- Interest Coverage Ratio eased to 29.75 in Q2 2025 per BDRX's latest filing, from 86.18 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 192.91 in Q2 2023 and troughed at 20.73 in Q3 2021.
- A 5-year average of 95.02 and a median of 86.18 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio plunged 97.51% in 2021, then jumped 659.34% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 20.73 in 2021, then jumped by 659.34% to 157.42 in 2022, then increased by 22.55% to 192.91 in 2023, then slumped by 55.32% to 86.18 in 2024, then slumped by 65.48% to 29.75 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 29.75, 86.18, and 192.91 for Q2 2025, Q4 2024, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 29.75 |
| Dec 31, 2024 | 86.18 |
| Jun 30, 2023 | 192.91 |
| Dec 31, 2022 | 157.42 |
| Sep 14, 2022 | 157.42 |
| Dec 31, 2021 | 20.73 |
| Sep 17, 2021 | 20.73 |
| Dec 31, 2020 | 53.46 |
| Sep 10, 2020 | 833.86 |
| Dec 31, 2019 | 116.68 |
| Dec 31, 2018 | 20.13 |
| Dec 31, 2016 | 174.57 |
| Dec 31, 2015 | 418.99 |
| Dec 31, 2014 | 60.17 |
| Dec 31, 2013 | 11.69 |